BC Platforms

BC Platforms, established in 1997 and headquartered in Zurich, Switzerland, is a prominent provider of healthcare data management and analytics services. The company specializes in delivering advanced genomic and clinical data solutions, crucial for driving personalized medicine and facilitating groundbreaking research. With a significant global presence indicated by its location count and a substantial revenue of $36.0B, BC Platforms operates with a workforce exceeding 10,000 employees. Its core offerings include a novel platform designed for secure, scalable, and value-driven data integration, supporting critical decision-making processes across the life sciences sector. The company's product suite encompasses bioinformatic software, data management systems, and analytical tools tailored for complex genomic data, enabling precise interpretation and actionable intelligence for healthcare providers and pharmaceutical partners. Meet BC Platforms's team to understand the expertise driving these innovations. The company's commitment to interoperability and data access positions it as a key player in transforming real-world data into improved patient care and drug development outcomes. BC Platforms actively contributes to the advancement of precision medicine through its robust technology platform and global network, supporting studies from biobanking to clinical trials. Explore financial highlights for detailed insights into their financial performance and funding rounds, which include Series A, B, and C investments, alongside other financing rounds, underscoring investor confidence in their mission and market position.